The distinction between atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS) and benign lipomatous tumors can be difficult, and fluorescent in situ hybridization (FISH) studies for MDM2 amplification have an established role in the pathological differential diagnosis [1–8]. This evidence concerns the gene MDM2 and benign lipomatous neoplasm.